Data management

McKesson and Aetion to combine RWE platform, EHR data

15-Oct-2019 By Melissa Fassbender

Aetion and McKesson today announced a strategic collaboration to advance the use of real world evidence in cancer research – offering joint solutions to support the FDA’s demonstration project and commercial customers.

Life Image, Graticule tie-up aims to mature the industry’s use of advanced data

14-Oct-2019 By Melissa Fassbender

The goal of the partnership between Life Image and Graticule is to improve clinical trial results and accelerate drug development, while reducing costs, say company executives.

Data deals: Parexel signs second RWD partnership this month

14-Oct-2019 By Melissa Fassbender

Parexel is incorporating real world data into ‘all aspects’ of clinical research via multi-year strategic partnership with Datavant.

Florence Healthcare raises $7.1m to build out ‘sponsor portal’

10-Oct-2019 By Melissa Fassbender

The clinical trials software company has raised $7.1m to connect its network of more than 5,000 clinical trial sites with sponsors and CROs via the ‘Florence eHub.’

Parexel boosts RWD network via HealthVerity partnership

08-Oct-2019 By Melissa Fassbender

Parexel increases its real world data network by more than 330m patients across 60 health care and consumer sources though a partnership with HealthVerity – which earlier this year raised $25m to advance its technology.

Datacubed deploys geofencing tech to detect adverse events, patient outcomes

08-Oct-2019 By Melissa Fassbender

Datacubed Health today launches the Linkt Location app, which tracks participant interactions with health care facilities, providing reminders and other communications to garner insight into health events that are often unreported.

Research on Research: New institute to advance ‘vital’ meta-research

07-Oct-2019 By Melissa Fassbender

The recently-launched Research on Research Institute aims to deliver “transformative and translational research on research systems, cultures, and decision-making,” the need for which “has never been more vital,” says director.

‘A completely new level of insight’: Iqvia unveils patient engagement solution

07-Oct-2019 By Melissa Fassbender

Iqvia’s Orchestrated Patient Engagement solution, powered by Belong.Life, delivers ‘hyper-personalized’ content to engage and support patients, providing insights that will benefit patients, life sciences companies, and the health care system, says CEO.

Elligo advancing RWD project under FDA grant

03-Oct-2019 By Melissa Fassbender

The FDA has awarded a grant to Elligo Health Research to continue work exploring the ability to extract clinical evidence from real-world data.

AstraZeneca looks to N-Side for ‘a single source of truth’

01-Oct-2019 By Melissa Fassbender

AstraZeneca is implementing N-Side’s recently launched Suite for Clinical Trials to provide ‘a single source of truth’ for safely supplying trials, as more stakeholders are generating more data.

Rho: 'The hurdles are high when you have a drug that the world doesn’t need'

01-Oct-2019 By Melissa Fassbender

Rho experts speak to the challenges facing drug development, meeting unmet needs, quality by design, and advances in technology, among other topics, during a sit-down at the CRO’s headquarters.

Pilot project to answer where and how RWE can be used

27-Sep-2019 By Melissa Fassbender

The Friends of Cancer Research, in collaboration with Iqvia and other health care research organizations, are working to determine where and when real-world data can be trusted.

A-Alpha Bio raises $2.8m to solve ‘major problems’ in early-stage drug development: CEO

25-Sep-2019 By Melissa Fassbender

A-Alpha Bio raises $2.8m from venture capital firms and angel investors to further develop its technology – and initiate drug discovery and optimization partnerships with pharmaceutical companies.

Elsevier developing risk calculator for DDIs ‘aligned with pharma’s needs and challenges’

24-Sep-2019 By Melissa Fassbender

To improve patient safety and reduce risk, Elsevier is developing an improved drug-drug interaction risk calculator in collaboration with several pharma partners, including Boehringer Ingelheim, Eli Lilly, and Servier.

InsightRX works to improve trial endpoints through precision dosing

24-Sep-2019 By Vassia Barba

InsightRX raises $10m in a Series A funding round to further develop its treatment individualization platform and broaden the therapeutic areas in which it’s applicable.